“Epidemiological and survival analysis of triple negative breast cancer cases in a retrospective multicentre study” comprising 257 TNBC cases collated from across five cancer centres in India has been accepted for publication. It should be out in a few months.

Next one summarizing data from >6500 Indian breast cancer cases, of all receptor types, is under preparation. Our goal is to exceed 10,000 cases within the year.

Our database of breast cancer samples, complete diagnosis and treatment info, combined with 3-5 year outcomes data offers tremendous opportunity to study Indian risk factors, identify optimal treatment paradigms for each subtype of patients, analyze cost-benefit ratio of different surgical/chemo/RT treatments, etc. We expect using them to also develop better prognostic, diagnostic and theranostic tests to improve survival in breast cancer patients.